Clinical Observation of SHAO's Five-needle Therapy for Active Ulcerative Colitis
10.13460/j.issn.1005-0957.2019.02.0160
- VernacularTitle:邵氏"五针法"治疗活动期溃疡性结肠炎临床观察
- Author:
Chun-Fen QUAN
1
;
Su-Ju SHAO
Author Information
1. 河南中医药大学第一附属医院
- Keywords:
Acupuncture therapy;
Colitis,Ulcerative;
Lung-intestine simultaneous treatment;
SHAO's five-needle therapy;
Sutherland Disease Activity Index;
Acupuncture medication combined
- From:
Shanghai Journal of Acupuncture and Moxibustion
2019;38(2):160-163
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of SHAO's five-needle therapy in treating active ulcerative colitis. Method By following a randomized controlled design, 57 patients with active ulcerative colitis were divided into a lung-intestine simultaneous treatment group of 28 cases and an intestine treatment group of 29 cases. The lung-intestine simultaneous treatment group was intervened by SHAO's five-needle therapy plus medications including oral administration of mesalazine, sulfasalazine suppositories via rectal insertion and Ge Gen Qin Lian decoction via enema; the intestine treatment group was intervened by medications. The two groups were both treated successively for4 weeks. The Sutherland Disease Activity Index (Sutherland DAI) was observed in the two groups and the release rate was also assessed; the main clinical symptom and sign scores of the two groups were recorded before and after treatment. Result The Sutherland DAI score dropped after treatment in both groups (P<0.05), and the between-group difference was statistically significant (P<0.05); the scores of abdominal pain, diarrhea and stool mixed with pus and blood declined after treatment in both groups (P<0.05), and the between-group differences were statistically significant (P<0.05); the lung-intestine simultaneous treatment group was superior to the intestine treatment group comparing plus medications the therapeutic efficacy regarding the symptoms and signs (P<0.05). Conclusion SHAO's five-needle therapy can rapidly release the clinical symptoms and body signs of active ulcerative colitis and enhance the clinical efficacy.
